Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis

Navina Chrobok (1) , John Bol (1) , Cornelis Jongenelen (1) , John Brevé (1) , Said El Alaoui (2) , Javier Fidalgo-Lopez (3) , Guy Fournet (3) , Benoît Joseph (3) , Micha Wilhelmus (1) , Benjamin Drukarch (1) , Anne-Marie van Dam (1)

1 Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
2 Covalab - Département Recherches [Villeurbanne, Lyon]
3 SMITh - Synthèse de Molécules d'Intérêt Thérapeutique

Domains: Chemical Sciences

Navina Chrobok, John Bol, Cornelis Jongenelen, John Brevé, Said El Alaoui, et al.. Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS ONE, 2018, 13 (12), pp.e0209522. ⟨10.1371/journal.pone.0209522⟩. ⟨hal-02134577⟩